Literature DB >> 18247128

Effect of morphine on the neuropathogenesis of SIVmac infection in Indian Rhesus Macaques.

Joanne K Marcario1, Mariam Riazi, Istvan Adany, Himanshu Kenjale, Kandace Fleming, Janet Marquis, Olga Nemon, Matthew S Mayo, Thomas Yankee, Opendra Narayan, Paul D Cheney.   

Abstract

Morphine is known to prevent the development of cell-mediated immune (CMI) responses and enhance expression of the CCR5 receptor in monocyte macrophages. We undertook a study to determine the effect of morphine on the neuropathogenesis and immunopathogenesis of simian immunodeficiency virus (SIV) infection in Indian Rhesus Macaques. Hypothetically, the effect of morphine would be to prevent the development of CMI responses to SIV and to enhance the infection in macrophages. Sixteen Rhesus Macaques were divided into three experimental groups: M (morphine only, n = 5), VM (morphine + SIV, n = 6), and V (SIV only, n = 5). Animals in groups M and VM were given 2.5 mg/kg of morphine sulfate, four times daily, for up to 59 weeks. Groups VM and V were inoculated with SIVmacR71/17E 26 weeks after the beginning of morphine administration. Morphine prevented the development of enzyme-linked immunosorbent spot-forming cell CMI responses in contrast to virus control animals, all of which developed CMI. Whereas morphine treatment had no effect on viremia, cerebrospinal fluid viral titers or survival over the time course of the study, the drug was associated with a tendency for greater build-up of virus in the brains of infected animals. Histopathological changes in the brains of animals that developed disease were of a demyelinating type in the VM animals compared to an encephalitic type in the V animals. This difference may have been associated with the immunosuppressive effect of the drug in inhibiting CMI responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18247128     DOI: 10.1007/s11481-007-9085-z

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  52 in total

1.  SIV-specific T lymphocyte responses in PBMC and lymphoid tissues of SIV-infected pigtailed macaques during suppressive combination antiretroviral therapy.

Authors:  Lucy M Carruth; M Christine Zink; Patrick M Tarwater; Michael D Miller; Ming Li; Laurie A Queen; Joseph L Mankowski; Anding Shen; Robert F Siliciano; Janice E Clements
Journal:  J Med Primatol       Date:  2005-06       Impact factor: 0.667

2.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

3.  Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry.

Authors:  Z Chen; P Zhou; D D Ho; N R Landau; P A Marx
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor.

Authors:  Chang-Jiang Guo; Yuan Li; Sha Tian; Xu Wang; Steven D Douglas; Wen-Zhe Ho
Journal:  J Investig Med       Date:  2002-11       Impact factor: 2.895

5.  Methadone induces CCR5 and promotes AIDS virus infection.

Authors:  Shunji Suzuki; Maria P Carlos; Linda F Chuang; José V Torres; Roy H Doi; Ronald Y Chuang
Journal:  FEBS Lett       Date:  2002-05-22       Impact factor: 4.124

6.  Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry.

Authors:  F Kirchhoff; S Pöhlmann; M Hamacher; R E Means; T Kraus; K Uberla; P Di Marzio
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

Review 8.  The cytotoxic T-lymphocyte response in HIV-1 infection.

Authors:  S A Kalams; B D Walker
Journal:  Clin Lab Med       Date:  1994-06       Impact factor: 1.935

Review 9.  The function of simian chemokine receptors in the replication of SIV.

Authors:  P A Marx; Z Chen
Journal:  Semin Immunol       Date:  1998-06       Impact factor: 11.130

10.  Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.

Authors:  K C Williams; S Corey; S V Westmoreland; D Pauley; H Knight; C deBakker; X Alvarez; A A Lackner
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

View more
  15 in total

1.  Enhanced pulmonary arteriopathy in simian immunodeficiency virus-infected macaques exposed to morphine.

Authors:  Leslie Spikes; Pranjali Dalvi; Ossama Tawfik; Haihua Gu; Norbert F Voelkel; Paul Cheney; Amy O'Brien-Ladner; Navneet K Dhillon
Journal:  Am J Respir Crit Care Med       Date:  2012-03-23       Impact factor: 21.405

2.  Comparison of the replication and persistence of simian-human immunodeficiency viruses expressing Vif proteins with mutation of the SLQYLA or HCCH domains in macaques.

Authors:  Kimberly Schmitt; M Sarah Hill; Zhenqian Liu; Autumn Ruiz; Nathan Culley; David M Pinson; Edward B Stephens
Journal:  Virology       Date:  2010-09-01       Impact factor: 3.616

3.  Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.

Authors:  Shiping Zou; Sylvia Fitting; Yun-Kyung Hahn; Sandra P Welch; Nazira El-Hage; Kurt F Hauser; Pamela E Knapp
Journal:  Brain       Date:  2011-11-18       Impact factor: 13.501

4.  Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons.

Authors:  Sylvia Fitting; Ruqiang Xu; Cecilia Bull; Shreya K Buch; Nazira El-Hage; Avindra Nath; Pamela E Knapp; Kurt F Hauser
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

Review 5.  Current understanding of HIV-associated neurocognitive disorders pathogenesis.

Authors:  Patrick Gannon; Muhammad Z Khan; Dennis L Kolson
Journal:  Curr Opin Neurol       Date:  2011-06       Impact factor: 5.710

6.  Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials.

Authors:  Mariam Riazi; Joanne K Marcario; Frank K Samson; Himanshu Kenjale; Istvan Adany; Vincent Staggs; Emily Ledford; Janet Marquis; Opendra Narayan; Paul D Cheney
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-13       Impact factor: 4.147

Review 7.  Nonhuman primate models of NeuroAIDS.

Authors:  Rachel Williams; Sirosh Bokhari; Peter Silverstein; David Pinson; Anil Kumar; Shilpa Buch
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

Review 8.  Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model.

Authors:  Richard J Noel; Vanessa Rivera-Amill; Shilpa Buch; Anil Kumar
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

9.  Effects of Morphine on Behavioral Task Performance in SIV-Infected Rhesus Macaques.

Authors:  Joanne K Marcario; Gurudutt Pendyala; Mariam Riazi; Kandace Fleming; Janet Marquis; Shannon Callen; Steven J Lisco; Stephen C Fowler; Paul D Cheney; Shilpa J Buch
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-02       Impact factor: 4.147

Review 10.  [Opioid-induced immunosuppression. A clinically relevant problem?].

Authors:  H L Rittner; A Brack
Journal:  Anaesthesist       Date:  2009-01       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.